e-SPACE Cardio-Renal-Metabolic 2023
Published: 25 March 2023
-
Views:
13017
-
Likes:
7
-
Views:
13017
-
Likes:
7
-
58m 8sPart 1 | Session 1 Plenary session 1 – HFpEF Andrew JS Coats, Giuseppe Rosano, Eberhard Standl, María José Soler, Stefan Anker
-
51m 57sPart 1 | Session 2 Satellite symposium – SGLT2 inhibitors in cardio-renal-metabolic patients – the perfect fit? (Supported by an educational grant from the Boehringer Ingelheim & Lilly Alliance) Stefan Anker, Paola Fioretto, Michel Jadoul
-
56m 38sPart 1 | Session 3 Plenary session 2 – SGLT2 updates Andrew JS Coats, Hiddo Lambers Heerspink, Antonio Ceriello, Gianluigi Savarese, Christoph Wanner
-
31m 38sPart 1 | Session 4 Meet the expert – Management of heart failure in real world clinical practice – insights from the REWOLUTION HF surveys Ewa Jankowska, Andrew JS Coats
-
58m 54sPart 1 | Session 5 Plenary session 3 – Weight management in CRM disease Luc Van Gaal, Wolfram Doehner, Milton Packer, Carel le Roux, Tammy Lyn Kindel, Ildiko Lingvay
-
30m 11sPart 1 | Session 6 Meet the expert – Implementation patterns and challenges in HF care: insights from the EVOLUTION HF study (Supported by an educational grant from AstraZeneca) Orly Vardeny, Gianluigi Savarese
-
1h 6m 3sPart 1 | Session 7 Plenary session 4 – Guidelines implementation for acutely ill patients Stephan Von Haehling, Mehriban Isgandar, Alexandre Mebazaa, Adriaan A Voors, Marat Fudim, Vijay Chopra
-
58m 41sPart 1 | Session 8 Plenary session 5 – Mineralocorticoids antagonists in CRM disease Javed Butler, Sunil Bhandari, Edgar V Lerma, Faiez Zannad, Janani Rangaswami, Gerasimos Filippatos
-
25m 15sPart 1 | Session 9 Meet the expert – Single pill combination (SPC) in Cardiorenal metabolic (CRM) disease Stefan Anker, Muthiah Vaduganathan
-
59m 5sPart 1 | Session 10 Plenary session 6 – Diuretics: old drugs, new data, new approaches Nisha Bansal, Christopher Wilcox, Wilfried Mullens, Areef Ishani, William T Abraham
-
1h 20sPart 2 | Session 1 Plenary session 7 – CRM drug management in patients with low eGFR and type 2 diabetes John J Atherton, Petar M Seferovic, John GF Cleland, Michael Böhm, Meg Jardine, Daniël van Raalte
-
43m 41sPart 2 | Session 2 Satellite symposium – Management of CKD without diabetes – SGLT2 inhibitors, the new standard of care (Supported by an educational grant from AstraZeneca) Michel Jadoul, David Wheeler, Pinar Topsever
-
1h 10sPart 2 | Session 3 Plenary session 8 – Diabetes and cardio-renal disease: the relevance of early treatment with the right drug Peter Rossing, Antonio Ceriello, Francesco Prattichizzo, Apostolos G Tsapas, Melanie Davies, John JV McMurray
-
31m 5sPart 2 | Session 4 Meet the expert – Management of hyperkalemia in cardiorenal disease ‒ practical guidance and novel therapeutic options (Supported by an unrestricted educational grant by CSL Vifor) Gianluigi Savarese, Jolanta Małyszko
-
59m 17sPart 2 | Session 5 Plenary session 9 – Managing “metals” Javed Butler, Shelley Zieroth, Iain Macdougall, John GF Cleland, Matthew R Weir, Paola Fioretto
-
41m 30sPart 2 | Session 6 Satellite symposium – Management of hyperkalemia across the cardiorenal spectrum (Supported by an educational grant from AstraZeneca) Matthew R Weir, Andrew JS Coats, Shelley Zieroth, Kieran McCafferty
-
1h 2m 16sPart 2 | Session 7 Plenary session 10 – Management of diabetes with kidney disease Peter Rossing, Sankar Navaneethan, Maria Luiza Caramori, Ian de Boer, Erin D Michos
-
1h 3m 10sPart 2 | Session 8 Plenary session 11 – Managing frail and elderly patients Fausto J Pinto, Mitja Lainscak, A Enrique Caballero, Cynthia Delgado, Ambarish Pandey
Overview
e-SPACE Cardio-Renal-Metabolic 2023 was the third edition of the annual global online conference that explores how leading experts, in cardiology, nephrology, and diabetology, are treating the interrelated diseases.
Course leadership Prof Stefan Anker (Berlin, DE), Dr Javed Butler (Texas, US), Prof Antonio Ceriello (Milan, IT), Prof Tara I Chang (California, US), Prof Ian de Boer (Washington, US), Prof Peter Rossing (Copenhagen, DK) and Prof Shelley Zieroth (Winnipeg, CA) lead an interactive programme of plenary sessions, meet the expert, case discussions and satellite symposium sessions focusing on the patient journey.
For the first time, e-SPACE Cardio-Renal-Metabolic 2023 brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, alongside KDIGO's mission to improve the care and outcomes of patients with kidney disease worldwide through the development and implementation of global clinical practice guidelines, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Learning Objectives
- Review the burden of diabetes, kidney disease and heart failure including morbidity, excess mortality, and reduced quality of life affecting individuals around the world
- Describe the complexity and interlink between the three conditions
- Discuss existing guidelines and best approaches for screening patients
- Review evidence-based management strategies for diabetes, cardiovascular disease, heart failure, kidney disease & obesity including SLGT2i, GLP-1RA, new non-steroidal mineralocorticoid receptor antagonists and other emerging therapies
- Foster cross-collaboration between other cardiorenal / metabolic specialists and primary care physicians and allied health care professionals in order to improve patients outcomes
Target Audience
- Cardiologists
- Nephrologists
- Diabetologists
- General Practitioners (GPs)
- HF Specialists
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Part 1
Day One
Part 2
Day Two
Faculty Biographies
Kerri L Cavanaugh
Associate Professor of Medicine
Dr Kerri L Cavanaugh is an Associate Professor of Medicine at Vanderbilt University Medical Center, Tennessee, US. She also serves as an attending physician at the Tennessee Valley Healthcare System Nashville VA.
She is the past medical director of the Vanderbilt Dialysis Clinic in-center and home dialysis programmes, including pediatrics, serving in the role for nearly ten years,
Dr Cavanaugh's research focuses on identifying ways to improve doctors’ and other health providers’ communication with patients and their families.
Fausto J Pinto
Professor of Cardiology
Fausto J Pinto, MD, PhD, FESC, FACC, FASE, FSCAI, is a Professor of Cardiology at Lisbon University Medical School and a Senior Consultant at the University Hospital of Santa Maria. He also serves as Director of the Lisbon Cardiovascular Institute. Professor Pinto serves or has served as President of the Association for Research and Development of the Faculty of Medicine (2004–2010), Chairman of the Congress Programme Committee of the European Society of Cardiology (2008–2010), President and Founder of the European Association of Echocardiography (2002–2004), and Councillor of the European Society of Cardiology (2004– 2006). In addition, he serves on the Editorial Board of several international journals and is Editor in Chief of the Portuguese Journal of Cardiology. Professor Pinto graduated from Lisbon University Medical School in 1984 and completed his cardiology fellowship at Santa Maria University Hospital in Lisbon and Stanford University Medical School, where he…
John Spertus
Cardiologist
Dr John A Spertus is a Cardiologist and Professor of Medicine at UMKC School of Medicine, Missouri, US.
Dr Spertus is a graduate of UCSF Medical School and completed his internal medicine, cardiology and health services training at the University of Washington.
His research focuses on methods for assessing patients’ health outcomes, measuring healthcare quality, and the use of information technology to guide medical decision-making based on risk-prediction models so that treatment can be safer, more cost-effective, evidence-based and patient-centered.
Giuseppe Paolisso
Professor of Internal Medicine and Geriatrics
Prof Giuseppe Paolisso is a Professor of Internal Medicine and Geriatrics at University of Campania Luigi Vanvitelli, Caserta, IT.
In 1981 he graduated in Medicine and Surgery at the University of Naples.
His main interests include diabetes, hypertension, arteriosclerosis and geriatrics, dedicating himself to the study of the molecular and metabolic aspects of aging and longevity.
Manjula Kurella Tamura
Professor of Medicine
Dr Manjula Kurella Tamura is Professor of Medicine at Stanford University, California, US.
She is a practicing nephrologist and clinical investigator with a research interest in evaluating the safety, effectiveness, and quality of kidney disease treatments in real-world populations.
Previously, she served in leadership roles for the National Kidney Foundation’s Kidney Early Evaluation Program, a nationwide kidney disease screening programme.
Suzanne Arnold
Associate Professor of Medicine
Dr Suzanne Arnold is an Associate Professor of Medicine at University of Missouri Kansas City, Missouri, US
She completed a residency in internal medicine and a fellowship in cardiovascular diseases at Washington University in St. Louis, Missouri. She also completed a research fellowship through the American Heart Association in cardiovascular outcomes research.
Dr Arnold's clinical interests include valvular heart disease, geriatric cardiology and quality of life.
Comments